May 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2024 Mar 31, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6 mln 442 mln
(-100.0 pct) (+253.1 pct)
Operating loss 176 mln loss 294 mln loss 1.18
Recurring loss 127 mln loss 289 mln loss 1.14
Net loss 128 mln loss 290 mln loss 1.14
EPS loss 3.33 yen loss 9.61 yen loss 29.50 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T